Advertisement
UK markets open in 4 hours 40 minutes
  • NIKKEI 225

    37,783.10
    +154.62 (+0.41%)
     
  • HANG SENG

    17,551.54
    +267.00 (+1.54%)
     
  • CRUDE OIL

    83.82
    +0.25 (+0.30%)
     
  • GOLD FUTURES

    2,346.00
    +3.50 (+0.15%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • Bitcoin GBP

    51,643.96
    +278.02 (+0.54%)
     
  • CMC Crypto 200

    1,391.86
    +9.29 (+0.67%)
     
  • NASDAQ Composite

    15,611.76
    -100.99 (-0.64%)
     
  • UK FTSE All Share

    4,387.94
    +13.88 (+0.32%)
     

Moderna's Flu Vaccine Struggles: Is Novavax Stock Now a Better Buy?

Moderna's Flu Vaccine Struggles: Is Novavax Stock Now a Better Buy?

Moderna (NASDAQ: MRNA) knows that it needs new products. The good news is that Moderna has three vaccine candidates in late-stage testing. Moderna reported more disappointing results for its experimental flu vaccine last week.